Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
Hummingbird Bioscience
University of Chicago
Maia Biotechnology
Istituto Oncologico Veneto IRCCS
AVEO Pharmaceuticals, Inc.
KaliVir Immunotherapeutics
Alpha Tau Medical LTD.
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
AstraZeneca
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
Seoul National University Bundang Hospital
Azienda Ospedaliero-Universitaria di Parma
University of Colorado, Denver
VLP Therapeutics
Maia Biotechnology
University of Pittsburgh
Institut de Cancérologie de Lorraine
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
University of Chicago
Radboud University Medical Center
New York University
Universitair Ziekenhuis Brussel
ImmVira Pharma Co. Ltd
Insel Gruppe AG, University Hospital Bern
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Bruce Robinson, MD
Bicara Therapeutics
Dana-Farber Cancer Institute
University of Pittsburgh
University of Pittsburgh
Indiana University
Abramson Cancer Center at Penn Medicine
Stanford University
Gruppo Oncologico del Nord-Ovest
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Women's College Hospital